Painful diabetic neuropathy

Lee C. Rogers, Rayaz Malik

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Diabetic polyneuropathy (DPN) is a devastating complication of diabetes that can lead to foot ulceration, Charcot foot, amputation, severe pain, and major psychological disorders. In 2000, it was estimated that 2.8% (171 million) of the world population had diabetes mellitus, and the WHO predicts that by the year 2030, this will rise to 4.4% (366 million). The greatest increases in diabetes prevalence will be seen in the Middle East, sub-Saharan Africa, and India (1). In the United States, recent reports estimate that 23.6 million people have diabetes (2). Roughly 50% of those with diabetes will develop DPN (3,4), and it is the leading cause of foot ulcers and nontraumatic limb amputation (5). In 2003, the annual cost of diabetic neuropathy was estimated to exceed $10.9 billion (6). The rise in diabetes and hence neuropathy prevalence with the high physical and financial costs demand greater attention and focused research in prevention and treatment of this debilitating complication.

Original languageEnglish
Title of host publicationHigh Risk Diabetic Foot
Subtitle of host publicationTreatment and Prevention
PublisherCRC Press
Pages65-79
Number of pages15
ISBN (Electronic)9781420083026
ISBN (Print)9781420083019
DOIs
Publication statusPublished - 1 Jan 2010

Fingerprint

Diabetic Neuropathies
Amputation
Foot
Foot Ulcer
Costs and Cost Analysis
Middle East
Africa South of the Sahara
Diabetes Complications
Type 2 Diabetes Mellitus
India
Diabetes Mellitus
Extremities
Psychology
Pain
Research
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rogers, L. C., & Malik, R. (2010). Painful diabetic neuropathy. In High Risk Diabetic Foot: Treatment and Prevention (pp. 65-79). CRC Press. https://doi.org/10.3109/9781420083026

Painful diabetic neuropathy. / Rogers, Lee C.; Malik, Rayaz.

High Risk Diabetic Foot: Treatment and Prevention. CRC Press, 2010. p. 65-79.

Research output: Chapter in Book/Report/Conference proceedingChapter

Rogers, LC & Malik, R 2010, Painful diabetic neuropathy. in High Risk Diabetic Foot: Treatment and Prevention. CRC Press, pp. 65-79. https://doi.org/10.3109/9781420083026
Rogers LC, Malik R. Painful diabetic neuropathy. In High Risk Diabetic Foot: Treatment and Prevention. CRC Press. 2010. p. 65-79 https://doi.org/10.3109/9781420083026
Rogers, Lee C. ; Malik, Rayaz. / Painful diabetic neuropathy. High Risk Diabetic Foot: Treatment and Prevention. CRC Press, 2010. pp. 65-79
@inbook{5290a2f8477a4e68a36473c4f17bd3fd,
title = "Painful diabetic neuropathy",
abstract = "Diabetic polyneuropathy (DPN) is a devastating complication of diabetes that can lead to foot ulceration, Charcot foot, amputation, severe pain, and major psychological disorders. In 2000, it was estimated that 2.8{\%} (171 million) of the world population had diabetes mellitus, and the WHO predicts that by the year 2030, this will rise to 4.4{\%} (366 million). The greatest increases in diabetes prevalence will be seen in the Middle East, sub-Saharan Africa, and India (1). In the United States, recent reports estimate that 23.6 million people have diabetes (2). Roughly 50{\%} of those with diabetes will develop DPN (3,4), and it is the leading cause of foot ulcers and nontraumatic limb amputation (5). In 2003, the annual cost of diabetic neuropathy was estimated to exceed $10.9 billion (6). The rise in diabetes and hence neuropathy prevalence with the high physical and financial costs demand greater attention and focused research in prevention and treatment of this debilitating complication.",
author = "Rogers, {Lee C.} and Rayaz Malik",
year = "2010",
month = "1",
day = "1",
doi = "10.3109/9781420083026",
language = "English",
isbn = "9781420083019",
pages = "65--79",
booktitle = "High Risk Diabetic Foot",
publisher = "CRC Press",

}

TY - CHAP

T1 - Painful diabetic neuropathy

AU - Rogers, Lee C.

AU - Malik, Rayaz

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Diabetic polyneuropathy (DPN) is a devastating complication of diabetes that can lead to foot ulceration, Charcot foot, amputation, severe pain, and major psychological disorders. In 2000, it was estimated that 2.8% (171 million) of the world population had diabetes mellitus, and the WHO predicts that by the year 2030, this will rise to 4.4% (366 million). The greatest increases in diabetes prevalence will be seen in the Middle East, sub-Saharan Africa, and India (1). In the United States, recent reports estimate that 23.6 million people have diabetes (2). Roughly 50% of those with diabetes will develop DPN (3,4), and it is the leading cause of foot ulcers and nontraumatic limb amputation (5). In 2003, the annual cost of diabetic neuropathy was estimated to exceed $10.9 billion (6). The rise in diabetes and hence neuropathy prevalence with the high physical and financial costs demand greater attention and focused research in prevention and treatment of this debilitating complication.

AB - Diabetic polyneuropathy (DPN) is a devastating complication of diabetes that can lead to foot ulceration, Charcot foot, amputation, severe pain, and major psychological disorders. In 2000, it was estimated that 2.8% (171 million) of the world population had diabetes mellitus, and the WHO predicts that by the year 2030, this will rise to 4.4% (366 million). The greatest increases in diabetes prevalence will be seen in the Middle East, sub-Saharan Africa, and India (1). In the United States, recent reports estimate that 23.6 million people have diabetes (2). Roughly 50% of those with diabetes will develop DPN (3,4), and it is the leading cause of foot ulcers and nontraumatic limb amputation (5). In 2003, the annual cost of diabetic neuropathy was estimated to exceed $10.9 billion (6). The rise in diabetes and hence neuropathy prevalence with the high physical and financial costs demand greater attention and focused research in prevention and treatment of this debilitating complication.

UR - http://www.scopus.com/inward/record.url?scp=85054941273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054941273&partnerID=8YFLogxK

U2 - 10.3109/9781420083026

DO - 10.3109/9781420083026

M3 - Chapter

AN - SCOPUS:85054941273

SN - 9781420083019

SP - 65

EP - 79

BT - High Risk Diabetic Foot

PB - CRC Press

ER -